TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Lundbeck Pharma A/S
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2020/12 |
Turnover |
23,773
|
25,373
|
25,855 |
Earnings before taxes |
3,232
|
3,235
|
-5,892 |
Total assets |
24,892
|
18,853
|
18,995 |
Current assets |
24,652
|
18,028
|
18,194 |
Current liabilities |
21,117
|
15,381
|
21,153 |
Equity capital |
3,774
|
6,944
|
-2,159 |
- share capital |
744
|
748
|
675 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2020/12 |
Solvency |
15.2%
|
36.8%
|
-11.4% |
Turnover per employee |
1,585
|
1,692
|
1,724 |
Profit as a percentage of turnover |
13.6%
|
12.7%
|
-22.8% |
Return on assets (ROA) | |||
Current ratio |
116.7%
|
117.2%
|
86.0% |
Return on equity (ROE) |
85.6%
|
46.6%
|
272.9% |
Change turnover |
-1,469
|
-3,304
|
2,531 |
Change turnover % |
-6%
|
-12%
|
11% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.